Related Experiment Video
Updated: May 19, 2026

JUMPn: A Streamlined Application for Protein Co-Expression Clustering and Network Analysis in Proteomics
Published on: October 19, 2021
Joint modeling of longitudinal and time-to-event data for dynamic disease risk prediction using proteomics
Markus Lindén1, Tea Ammunét1, Tommi Välikangas1
1Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
None:
Biomedical studies increasingly incorporate longitudinal data, enabling us to track individual disease processes over time at the molecular level, and to discover associations of the molecular profiles with the outcome of interest, such as the onset of a disease. Despite the potential of statistical methods that jointly model longitudinal and time-to-event data, they have not yet been widely adopted in high-throughput omics studies. Therefore, we evaluated multiple approaches for joint modeling of longitudinal and time-to-event data, and we introduce a joint modeling strategy for longitudinal proteomics studies. The focus is on assessing the utility of the methods in predicting the dynamic disease risk of an individual from longitudinal proteome profiles. To benchmark the methods, we used a range of simulated datasets that reflected real proteome profiles with varying complexities. Our results clearly demonstrated the advantages of the longitudinal methods over conventional Cox proportional hazards models with single time point studies. This was further supported by re-analysis of data from a proteomics study of early type 1 diabetes prediction, where we discovered new early candidate proteins associated with the disease onset that were not detected in the original study.
Related Concept Videos
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time until a...
Model Approaches for Pharmacokinetic Data: Physiological Models
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Cancer Survival Analysis
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Statistical Methods for Analyzing Epidemiological Data